vs

Side-by-side financial comparison of Dexcom (DXCM) and Realty Income (O). Click either name above to swap in a different company.

Realty Income is the larger business by last-quarter revenue ($1.5B vs $1.3B, roughly 1.2× Dexcom). Dexcom runs the higher net margin — 21.2% vs 19.9%, a 1.3% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 11.0%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 8.6%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Realty Income Corporation is a real estate investment trust that invests in free-standing, single-tenant commercial properties in the United States, the United Kingdom, and six other countries in Europe. These properties are subject to NNN Leases. The company is organized in Maryland with its headquarters in San Diego, California.

DXCM vs O — Head-to-Head

Bigger by revenue
O
O
1.2× larger
O
$1.5B
$1.3B
DXCM
Growing faster (revenue YoY)
DXCM
DXCM
+10.6% gap
DXCM
21.6%
11.0%
O
Higher net margin
DXCM
DXCM
1.3% more per $
DXCM
21.2%
19.9%
O
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
8.6%
O

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DXCM
DXCM
O
O
Revenue
$1.3B
$1.5B
Net Profit
$267.3M
$296.1M
Gross Margin
62.9%
Operating Margin
25.6%
21.7%
Net Margin
21.2%
19.9%
Revenue YoY
21.6%
11.0%
Net Profit YoY
153.6%
48.3%
EPS (diluted)
$0.67
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
O
O
Q1 26
$1.3B
Q4 25
$1.3B
$1.5B
Q3 25
$1.2B
$1.5B
Q2 25
$1.2B
$1.4B
Q1 25
$1.0B
$1.4B
Q4 24
$1.1B
$1.3B
Q3 24
$994.2M
$1.3B
Q2 24
$1.0B
$1.3B
Net Profit
DXCM
DXCM
O
O
Q1 26
$267.3M
Q4 25
$267.3M
$296.1M
Q3 25
$283.8M
$315.8M
Q2 25
$179.8M
$196.9M
Q1 25
$105.4M
$249.8M
Q4 24
$151.7M
$199.6M
Q3 24
$134.6M
$269.5M
Q2 24
$143.5M
$259.4M
Gross Margin
DXCM
DXCM
O
O
Q1 26
62.9%
Q4 25
62.9%
Q3 25
60.5%
Q2 25
59.5%
Q1 25
56.9%
Q4 24
58.9%
Q3 24
59.7%
Q2 24
62.4%
Operating Margin
DXCM
DXCM
O
O
Q1 26
25.6%
Q4 25
25.6%
21.7%
Q3 25
20.1%
23.2%
Q2 25
18.4%
15.8%
Q1 25
12.9%
19.3%
Q4 24
17.0%
16.5%
Q3 24
15.3%
21.5%
Q2 24
15.7%
20.7%
Net Margin
DXCM
DXCM
O
O
Q1 26
21.2%
Q4 25
21.2%
19.9%
Q3 25
23.5%
21.5%
Q2 25
15.5%
14.0%
Q1 25
10.2%
18.1%
Q4 24
13.6%
14.9%
Q3 24
13.5%
20.2%
Q2 24
14.3%
19.4%
EPS (diluted)
DXCM
DXCM
O
O
Q1 26
$0.67
Q4 25
$0.67
$0.32
Q3 25
$0.70
$0.35
Q2 25
$0.45
$0.22
Q1 25
$0.27
$0.28
Q4 24
$0.37
$0.23
Q3 24
$0.34
$0.30
Q2 24
$0.35
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
O
O
Cash + ST InvestmentsLiquidity on hand
$917.7M
$434.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$39.4B
Total Assets
$6.3B
$72.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
O
O
Q1 26
$917.7M
Q4 25
$917.7M
$434.8M
Q3 25
$1.8B
$417.2M
Q2 25
$1.2B
$800.4M
Q1 25
$904.9M
$319.0M
Q4 24
$606.1M
$445.0M
Q3 24
$621.2M
$397.0M
Q2 24
$939.2M
$442.8M
Stockholders' Equity
DXCM
DXCM
O
O
Q1 26
$2.7B
Q4 25
$2.7B
$39.4B
Q3 25
$2.7B
$39.1B
Q2 25
$2.6B
$39.2B
Q1 25
$2.3B
$39.0B
Q4 24
$2.1B
$38.8B
Q3 24
$2.0B
$38.5B
Q2 24
$2.4B
$38.6B
Total Assets
DXCM
DXCM
O
O
Q1 26
$6.3B
Q4 25
$6.3B
$72.8B
Q3 25
$7.5B
$71.3B
Q2 25
$7.3B
$71.4B
Q1 25
$6.8B
$69.8B
Q4 24
$6.5B
$68.8B
Q3 24
$6.4B
$68.5B
Q2 24
$6.8B
$68.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
O
O
Operating Cash FlowLast quarter
$1.2B
Free Cash FlowOCF − Capex
$1.2B
FCF MarginFCF / Revenue
77.6%
Capex IntensityCapex / Revenue
3.3%
Cash ConversionOCF / Net Profit
4.06×
TTM Free Cash FlowTrailing 4 quarters
$3.9B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
O
O
Q1 26
Q4 25
$294.0M
$1.2B
Q3 25
$659.9M
$943.1M
Q2 25
$303.0M
$1.1B
Q1 25
$183.8M
$787.5M
Q4 24
$301.4M
$972.0M
Q3 24
$199.5M
$841.5M
Q2 24
$279.4M
$981.2M
Free Cash Flow
DXCM
DXCM
O
O
Q1 26
Q4 25
$192.1M
$1.2B
Q3 25
$579.4M
$909.9M
Q2 25
$208.9M
$1.0B
Q1 25
$96.8M
$764.6M
Q4 24
$176.8M
$935.8M
Q3 24
$88.3M
$807.9M
Q2 24
$213.3M
$939.2M
FCF Margin
DXCM
DXCM
O
O
Q1 26
Q4 25
15.3%
77.6%
Q3 25
47.9%
61.9%
Q2 25
18.1%
73.3%
Q1 25
9.3%
55.4%
Q4 24
15.9%
69.8%
Q3 24
8.9%
60.7%
Q2 24
21.2%
70.1%
Capex Intensity
DXCM
DXCM
O
O
Q1 26
Q4 25
8.1%
3.3%
Q3 25
6.7%
2.3%
Q2 25
8.1%
1.9%
Q1 25
8.4%
1.7%
Q4 24
11.2%
2.7%
Q3 24
11.2%
2.5%
Q2 24
6.6%
3.1%
Cash Conversion
DXCM
DXCM
O
O
Q1 26
Q4 25
1.10×
4.06×
Q3 25
2.33×
2.99×
Q2 25
1.69×
5.39×
Q1 25
1.74×
3.15×
Q4 24
1.99×
4.87×
Q3 24
1.48×
3.12×
Q2 24
1.95×
3.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

O
O

Product And Service Retail$900.8M61%
Other$531.5M36%

Related Comparisons